Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

Getting Arikayce (Amikacin Liposome Inhalation) Covered by Blue Cross Blue Shield in New Jersey: Complete Guide to Prior Authorization and Appeals

Answer Box: Fast Track to Arikayce Coverage in New Jersey Arikayce (amikacin liposome inhalation) requires prior authorization from Horizon Blue Cross Blue Shield of New Jersey for refractory MAC lung disease. To get approved: (1) Submit PA request with 6+ months of failed standard MAC therapy documentation, (2) Include positive
6 min read

How to Get Firdapse (amifampridine) Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Firdapse Covered by Blue Cross Blue Shield in Washington Firdapse (amifampridine) requires prior authorization from Blue Cross Blue Shield plans in Washington for Lambert-Eaton myasthenic syndrome (LEMS). To get approval: (1) Ensure confirmed LEMS diagnosis with EMG and anti-VGCC antibodies by a neuromuscular specialist, (2) Submit PA
6 min read

How Long Does It Take to Get Mycapssa (Octreotide, Oral) Approved by Blue Cross Blue Shield in Florida? Complete Timeline Guide

Answer Box: Getting Mycapssa Approved by Florida Blue Cross Blue Shield Florida Blue Cross Blue Shield (Florida Blue) requires prior authorization for Mycapssa (oral octreotide) with standard approval taking 7-30 days and expedited review in 24-72 hours. You'll need documented acromegaly diagnosis, prior injectable somatostatin analog trial (octreotide
6 min read

How to Get Kineret (Anakinra) Covered by Blue Cross Blue Shield in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Kineret Covered in North Carolina Blue Cross Blue Shield of North Carolina typically requires prior authorization for Kineret (anakinra), including documented failure of conventional DMARDs and specialist attestation. The fastest path: Work with your rheumatologist to submit a comprehensive medical necessity letter documenting failed therapies and current
6 min read